BNP Paribas Financial Markets’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$267K Buy
19,082
+10,367
+119% +$145K ﹤0.01% 2874
2025
Q1
$118K Sell
8,715
-7,228
-45% -$98.3K ﹤0.01% 3150
2024
Q4
$325K Sell
15,943
-11,682
-42% -$238K ﹤0.01% 2757
2024
Q3
$805K Buy
27,625
+19,259
+230% +$561K ﹤0.01% 1926
2024
Q2
$194K Sell
8,366
-63,739
-88% -$1.48M ﹤0.01% 2448
2024
Q1
$1.48M Sell
72,105
-119,538
-62% -$2.45M ﹤0.01% 1672
2023
Q4
$4.11M Buy
191,643
+28,817
+18% +$618K ﹤0.01% 1065
2023
Q3
$3.36M Buy
162,826
+55,344
+51% +$1.14M ﹤0.01% 1109
2023
Q2
$3.17M Sell
107,482
-30,590
-22% -$903K ﹤0.01% 1057
2023
Q1
$3.18M Buy
138,072
+80,384
+139% +$1.85M ﹤0.01% 1118
2022
Q4
$1.6M Sell
57,688
-50,881
-47% -$1.42M ﹤0.01% 1347
2022
Q3
$3.33M Buy
108,569
+86,237
+386% +$2.65M 0.01% 1132
2022
Q2
$657K Buy
22,332
+14,089
+171% +$415K ﹤0.01% 1926
2022
Q1
$265K Sell
8,243
-11,456
-58% -$369K ﹤0.01% 2475
2021
Q4
$879K Buy
19,699
+1,700
+9% +$75.8K ﹤0.01% 2107
2021
Q3
$908K Buy
17,999
+11,951
+198% +$603K ﹤0.01% 1902
2021
Q2
$474K Sell
6,048
-4,854
-45% -$381K ﹤0.01% 1992
2021
Q1
$623K Buy
10,902
+1,006
+10% +$57.4K ﹤0.01% 1931
2020
Q4
$829K Sell
9,896
-5,006
-34% -$419K ﹤0.01% 1566
2020
Q3
$534K Buy
14,902
+8,303
+126% +$297K ﹤0.01% 1617
2020
Q2
$160K Sell
6,599
-15,982
-71% -$386K ﹤0.01% 1977
2020
Q1
$395K Buy
22,581
+15,502
+219% +$271K ﹤0.01% 1916
2019
Q4
$123K Sell
7,079
-1,699
-19% -$29.6K ﹤0.01% 2538
2019
Q3
$134K Buy
8,778
+2,266
+35% +$34.7K ﹤0.01% 2336
2019
Q2
$135K Sell
6,512
-4,144
-39% -$86K ﹤0.01% 2249
2019
Q1
$247K Buy
10,656
+9,470
+798% +$220K ﹤0.01% 2008
2018
Q4
$24.5K Sell
1,186
-602
-34% -$12.4K ﹤0.01% 2362
2018
Q3
$38.9K Buy
1,788
+537
+43% +$11.7K ﹤0.01% 2491
2018
Q2
$19.1K Sell
1,251
-1,813
-59% -$27.6K ﹤0.01% 2870
2018
Q1
$60.3K Buy
+3,064
New +$60.3K ﹤0.01% 2886